|
End-of-day quote
Korea S.E.
2026-10-23
|
5-day change | 1st Jan Change | ||
| 9,700.00 KRW | -3.39% |
|
+5.09% | +42.23% |
| 12-09 | GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy | CI |
| 25-06-12 | GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut | MT |
Chart: Technical Analysis
Korea S.E.KRW
| Markets | Quality | ||
|---|---|---|---|
Korea S.E.
| A340450 | End-of-day quote |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 10,250 | 10,250 | 9,870 |
| Spread/Res. | -5.37% | -5.37% | -1.72% |
| Spread/Supp. | +31.08% | +43.28% | +48.09% |
| Support | 7,400 | 6,770 | 6,550 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- A340450 Stock
- Charts GC Genome Corporation
Select your edition
All financial news and data tailored to specific country editions
